Details of first reliable CJD test revealed

January 15, 1999

Researchers have developed the first reliable test for new variant Creutzfeldt-Jakob disease (CJD) that can be used while the patient is still alive. Details are revealed in this week's Lancet. The test, developed under John Collinge at Imperial College, London, identifies rogue prion proteins in tonsil tissue and means doctors could test the general population.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments